Search results
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 2 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19...
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 18 hours agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and last traded at $29.13. Approximately ...
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 2 days agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
Lady Gaga Reveals She Played 5 Shows With COVID: 'Didn't Want To Let All The Fans Down'
HuffPost· 9 hours agoThe confession at her "Gaga Chromatica Ball" concert film premiere Thursday was met with raucous...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 2 days agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 16 hours ago(The long-term annual average return of the S&P 500 is around 10%.) If you're looking for very...
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
The Motley Fool via AOL· 4 days agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most successful investors bought millions of shares in the first quarter.
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 1 day agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 4 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 14 hours agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...